Publication | Open Access
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
101
Citations
11
References
2019
Year
Our findings aid interpretation of changes in EORTC QLQ-C30 scores over time, both within and between groups, and for performing more accurate sample size calculations for clinical trials in advanced breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1